Consulta: creatorFacets:"Atalla,Angelo"
Registros recuperados: 1
Data/hora: 08/06/2024 14:31:36

A non-randomized comparative study using different doses of acyclovir to prevent herpes simplex reactivation in patients submitted to autologous stem cell transplantation
Provedor de dados: Brazilian Journal of Infectious Diseases
Autores: Atalla,Angelo; Maiolino,Angelo; Guimarães,Maria Angélica; Guimarães,Antonio Carlos; Nucci,Marcio.
The reactivation of Herpes Simplex virus (HSV) occurs in 70% to 80% of patients submitted to autologous stem cell transplantation (ASCT); it increases the severity of chemotherapy-induced mucositis. Therefore, the use of acyclovir in ASCT patients is considered standard practice. However, the minimum dose needed to prevent reactivation is a matter of debate. We compared two doses of acyclovir in a non-randomized fashion in 59 patients submitted to ASCT: 32 patients received a dose of 125 mg/m² IV every six hours and the subsequent 27 patients received a dose of 60 mg/m² IV every six hours. Viral excretion was evaluated through weekly viral culture of oral swabs. Grade 4 mucositis was more frequent in Group 1 (p= 0.03). The reactivation rates in Groups 1...
Tipo: Info:eu-repo/semantics/article
Palavras-chave: Acyclovir; Prophylaxis; Stem cell transplantation.
Ano: 2005
URL: http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1413-86702005000400010